Expertise in
22
conditions

Dr. William N. Harwin

Hematology | Oncology
Florida Cancer Specialists P L
15681 New Hampshire Ct, 
Fort Myers, FL 
Expertise in
22
conditions
Florida Cancer Specialists P L
15681 New Hampshire Ct, 
Fort Myers, FL 

Overview

William Harwin is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida.

Dr. Harwin is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 5 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Florida Cancer Specialists P L
15681 New Hampshire Ct, Fort Myers, FL 33908
Other Locations
Florida Cancer Specialists & Research Institute LLC
8260 Gladiolus Dr, Fort Myers, FL 33908

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Drug: Adjuvant Chemotherapy
Study Phase: Not Applicable
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

5 Total Publications

TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 02, 2017
Similar Doctors
Expertise in
31
conditions
Dr. Lowell L. Hart
Hematology | Oncology
Expertise in
31
conditions
Dr. Lowell L. Hart
Hematology | Oncology
Referral may be required

Florida Cancer Specialists Pl

8260 Gladiolus Dr, 
Fort Myers, FL 
 (0.6 miles away)
239-437-5755
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Lowell Hart is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Hart is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Hart is board certified in American Board Of Internal Medicine. Dr. Hart is currently accepting new patients.

Expertise in
65
conditions
Dr. Syed F. Zafar
Hematology | Oncology
Expertise in
65
conditions
Dr. Syed F. Zafar
Hematology | Oncology
Referral may be required

Florida Cancer Specialists Pl

8260 Gladiolus Dr, 
Fort Myers, FL 
 (0.6 miles away)
239-437-5755
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Syed Zafar is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Zafar is highly rated in 65 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Familial Colorectal Cancer. Dr. Zafar is board certified in American Board Of Internal Medicine. Dr. Zafar is currently accepting new patients.

Expertise in
21
conditions
Dr. Vanrajsinh G. Rana
Hematology | Oncology
Expertise in
21
conditions
Dr. Vanrajsinh G. Rana
Hematology | Oncology
Referral may be required

Florida Cancer Specialists P L

4371 Veronica S Shoemaker Blvd, 
Fort Myers, FL 
 (6.8 miles away)
239-274-8200
Languages Spoken:
English
See accepted insurances

Vanrajsinh Rana is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Rana is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Febrile Neutropenia, and Nasopharyngeal Carcinoma.

Frequently Asked Questions about Dr. William N. Harwin

How do I make an appointment with Dr. William N. Harwin?

You can book an appointment with Dr. William N. Harwin by calling their office at 239-437-4444. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. William N. Harwin a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. William N. Harwin is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. William N. Harwin specialize in?

While Dr. William N. Harwin is a Hematology, they have specific expertise in Paget Disease of the Breast, Inflammatory Breast Cancer, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. William N. Harwin participate in research or clinical trials?

Yes. Dr. William N. Harwin has published 5 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. William N. Harwin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. William N. Harwin accept my insurance?

Dr. William N. Harwin accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 239-437-4444 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Harwin's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 84 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile